{"name":"Topical Remedy","slug":"topical-remedy","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Merlin","genericName":"Merlin","slug":"merlin","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Merlin","genericName":"Merlin","slug":"merlin","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE10TXI2MHNiN0lyeHRnZF9YdzA3UlE4NTR4NTZrMGZXMmxPczRsZUdjaFJzMUFxWjI4TEZDTXBMZTlXSWJuTDFJR001bDEyNk9yTWROekt2eVAxR3dZOHNZSkF5VExNMW5xTDg0bzhEMkxUUQ?oc=5","date":"2026-02-27","type":"pipeline","source":"Britannica","summary":"Prescription Drug Costs - Britannica","headline":"Prescription Drug Costs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQQlB0MTRaalNNZVotdER5RVQwdjJGR1ZEb0ZnQUVzYVI2am9HaVNGaVJxQmNpUEFta1M0bUJ2eWUzWFp1cmg2OUJic0dPODMxSzdwVmFYZ1V3UjIwd0d5TC1FMmlodERuNnpMTXcxNlM4VFc3NDZBbjJoY3hVYU9uenk2ZlRiOElGbkU0blRvVXR3TkczUFA5Zw?oc=5","date":"2025-12-03","type":"trial","source":"Fierce Pharma","summary":"Cosmo shares zoom with results from 2 male-pattern hair loss trials - Fierce Pharma","headline":"Cosmo shares zoom with results from 2 male-pattern hair loss trials","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-02","type":"regulatory","source":"PR Newswire","summary":"AOB Pharma receives European Medicines Agency (EMA) positive decision on the pediatric investigation plan (PIP), supporting future development of B244 for the treatment of mild to moderate atopic derm","headline":"AOB Pharma receives European Medicines Agency (EMA) positive decision on the pediatric investigation plan (PIP), support","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE9CdlNTcUJYbk9GMm5XNXpNbEtQSDl1ZkhDdEZOWVdIdlctRWxIbkRXZkQ5N3hNd3dDQjV2TXNtM0RGOHlWZ3YtbENVTHJIcFZ5QjhEZFI2T00?oc=5","date":"2025-11-05","type":"pipeline","source":"The Pharma Letter","summary":"Moberg Pharma - The Pharma Letter","headline":"Moberg Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxOX3l3SGl3aXBDcWN2SkwwU09NZ1o1dDQwLUk5TWp3R21jdkxsU0FNNE0tWFVocGgzRGZBTkJqTTZENWdDVVJaMlJpV2I0Q2NETi1qYi1fNDRsQ1RaQTFvbG54cDc5dEJrVnBqa3pzVTk1RWJCeElXNE0zcUdZSzN5eF9ieVRwS0h2OFdlY0E4Wnk5MVJka09YWndSVHJJZW0waEIwYU9OVHhMcEoxZnNXU0JPSENwaXJDWThCa01xRFE3RTBrSGVYXzVnR3hPX2lu?oc=5","date":"2025-11-05","type":"pipeline","source":"Business Wire","summary":"LEO Pharma Announces NICE Recommendation of Reimbursement in England and Wales - Business Wire","headline":"LEO Pharma Announces NICE Recommendation of Reimbursement in England and Wales","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-03","type":"pipeline","source":"Business Wire","summary":"United States Vitiligo Forecast Report 2025: A $320+ Million Market by 2033 Featuring Incyte, BMS, Clinuvel Pharmaceuticals, Astellas Pharma, Baxter, Pfizer, Dr. Reddy's Laboratories - ResearchAndMark","headline":"United States Vitiligo Forecast Report 2025: A $320+ Million Market by 2033 Featuring Incyte, BMS, Clinuvel Pharmaceutic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOdkY2RTZaTTcxNlAzc1hCcHZFRG1SdVZwZUlpT1ROR3hsWXlrNmVXWjNCUDYwRFRXZ2hSc3p3X2pxcHFZZkt5ajNiT25iS21scGtiNEhoX0pIZHlvalBSR0U0SmlZVlJuV3lCZUhfek9vSUxSdVluenB6dVhFa1U0Vk5iQjd2MUpXdjBiZHZXVWhJUHE1Q3didTNzY2VNdjF2bXM3MmJreXN0NVloOU1xYTZneVEzeE9NQV81ZHBIdThyX29UM1pDWF9KZnB4bFFmRzFYXy1IRTQ0cENadFdTalVSa0g?oc=5","date":"2025-08-27","type":"regulatory","source":"BioSpace","summary":"LEO Pharma Announces Health Canada Approval of Anzupgo® for Treatment of Moderate to Severe Chronic Hand Eczema - BioSpace","headline":"LEO Pharma Announces Health Canada Approval of Anzupgo® for Treatment of Moderate to Severe Chronic Hand Eczema","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxNcVFRU0pXR0p4VXJYR1lnWC1sQUpGZjk1QnMwUW9nT2d2TFpVMFpmNXVqR3cwR3Q4RHFCQjBYblV5SElDb1JTZ3RuZlBqSFhzSWdzY1hwdHhkQU03SGVTTWxqNFlWTnZERjVENXJKSk1ic2pFSm9BbkJVOUJJaWl2cDhJZHJoZERiZmV2bG16OWZBT1RoTGYweUZ0eTgxUzExUWxhUmFxVnFLcHU5aGc1UGRjWHgtWkNNaFV4QTV1SlBWS0M4MkJNMXRmLUxUcE0?oc=5","date":"2025-07-24","type":"regulatory","source":"Pharmacy Times","summary":"Delgocitinib Cream Becomes First, Only Approved Treatment for Moderate-to-Severe Chronic Hand Eczema - Pharmacy Times","headline":"Delgocitinib Cream Becomes First, Only Approved Treatment for Moderate-to-Severe Chronic Hand Eczema","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOMm45RkRtdDVVc1dDTnpXT19yWndqZDFUR0dPWk53NkJtQzV0VVVKaGk3YmJsOTNDSWM5RjFxRmN3S1NoUWMydncyZzgxNUZIdTVEQkRhWHk1dmlRU3A2TkRsX3FZc2VDWjdwdjFRYTBNSEl2WWVwbkJ3dVlGbVp6ZjkzX0lvbC02U0VqUWpzR1pzYlB1R2c?oc=5","date":"2025-07-24","type":"regulatory","source":"Fierce Pharma","summary":"Leo roars to key FDA nod for Anzupgo to treat chronic hand eczema - Fierce Pharma","headline":"Leo roars to key FDA nod for Anzupgo to treat chronic hand eczema","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQRl9yOFVZNXdqNXlZdnhYZFZVMjczUEpsTWpVc0N5aUpYcVpCS24yelYzM2pYTGNNYktFVGlPWGpMZFZXWjBaVzBVa2p3TUplZkpNZGVrVVc4d3dBcG5oWmU5ek9LMkV5VUJnRnZhZVIyeDg1OGJqMHlselk2VzliR1NkaU9tSDBGMUdaRy0ydGYyOW15dDEtX1FwWUgtSGRoMWtraklQSnM4eFU2Vi1ES1JOUlgxYms1YkYxeTB4ekZlRVpmS1RjN0VyNWtiRGlPNzN4dlVoYy1hVVcw?oc=5","date":"2025-07-23","type":"regulatory","source":"STT Info","summary":"LEO Pharma Announces FDA Approval of ANZUPGO ® (delgocitinib) Cream in the U.S. - STT Info","headline":"LEO Pharma Announces FDA Approval of ANZUPGO ® (delgocitinib) Cream in the U.S.","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNd2Q5cE9jNWtWdDNzbWV6TGswVFBibFlqVGU0QkRxam9LNm0tYmszdXdSSl85eDBGV1pQZjBQZUJxTVhSNFY3Ykhqa0RmNFU5RW15bTlJd2F6TWZ6eXhkSmFGdmtZWlpKMW1URW5rRTd0dUhwRllIbnFBWjY1d0FmenVhUGI4SVpaOEJ5NGhmeU9ELXJ3TVYzT2g4T2NQRElydWlEZUNFZEh5Yl90LVZWUXdXdEZOcEUyQmNySG5iT3pBNGNiZGtPT0tWQWhnQQ?oc=5","date":"2025-07-07","type":"pipeline","source":"The Medicine Maker","summary":"Can a Spider Venom-Inspired Peptide Revolutionize Sexual Dysfunction Medicine? - The Medicine Maker","headline":"Can a Spider Venom-Inspired Peptide Revolutionize Sexual Dysfunction Medicine?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQY3doQXBsODQ5MkJmT09ib0RhbWhySFNvZWduUjdCeko3c0VoQi05TzRDTC1DNWlqVzh3QldZUHp3VzlFTXNmTF9Fa0l1LTdlUERkdlpPSlNyRktOTEkxWWhKMDFWZm1sMnh4SlJIQlg1aGVxYW1aUnhMN1dQUGtfRVpwOV8tQ1ljQmZlZXFsVHkxSm1SNHRWbjlVUFdZbGlTRkxHbg?oc=5","date":"2025-04-17","type":"pipeline","source":"grandviewresearch.com","summary":"Topical Drugs Contract Manufacturing Market Report, 2030 - grandviewresearch.com","headline":"Topical Drugs Contract Manufacturing Market Report, 2030","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}